Aralez Pharm Inc (ARLZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 50,056 | 73,959 | 92,351 | N/A |
| Receivables | N/A | N/A | 113 | N/A |
| TOTAL | $50,610 | $74,035 | $92,671 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 425 | 109 | 159 | N/A |
| TOTAL | $425 | $109 | $159 | $N/A |
| Total Assets | $51,035 | $74,144 | $92,830 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 179 | 194 | 128 | 0 |
| Accrued Expenses | 1,657 | 3,329 | 3,634 | N/A |
| TOTAL | $1,836 | $3,523 | $3,762 | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,836 | $3,523 | $3,762 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 28,150 | 28,078 | N/A | N/A |
| Common Shares | 28 | 339 | 454 | N/A |
| Retained earnings | -94,356 | -69,801 | -48,099 | N/A |
| Other shareholders' equity | -510 | -3,429 | -6,617 | 0 |
| TOTAL | $49,199 | $70,621 | $89,068 | $N/A |
| Total Liabilities And Equity | $51,035 | $74,144 | $92,830 | $0 |